Ranjitkar Manandhar, Nora, Gyan Krishna Kayastha, and Paras Kumar Acharya. 2018. “Dasatinib Tyrosine Kinase Inhibitor As Second and Third Line Therapy in Chronic Myeloid Leukemia: Outcome of a Nepalese Study”. Journal of Patan Academy of Health Sciences 5 (1):47-56. https://jpahs.edu.np/index.php/jpahs/article/view/97.